All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells

Cell Growth and Differentiation

Volumn 8, Issue 6, 1997, Pages 631-641

  Seewaldt, Victoria L ^a   Kim, Ji Hyon ^a   Caldwell, Leslie E ^a   Johnson, Barton S ^a   Swisshelm, Karen ^a   Collins, Steven J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; ONCOPROTEIN; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL CYCLE G1 PHASE; CELL GROWTH; CONTROLLED STUDY; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; BLOTTING, NORTHERN; BREAST; BREAST NEOPLASMS; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA; EPITHELIAL CELLS; EPITHELIUM; G1 PHASE; GENE EXPRESSION REGULATION; GROWTH INHIBITORS; HUMANS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, RETINOIC ACID; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TRETINOIN;

EID: 0030922542     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Love, J. M., and Gudas, L. J. Vitamin A, differentiation and cancer. Curr. Opin. Cell Biol., 6: 825-831, 1994.
2. Gudas, L. J. Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth & Differ., 3: 655-662, 1992.
3. Chambon, P. The retinoid signaling pathway: molecular and genetic analyses. Semin. Cell Biol., 5: 115-125, 1994.
4. Lippman, S. M., Benner, S. E., and Hong, W. K. Cancer chemoprevention. J. Clin. Oncol., 12: 851-873, 1994.
5. Smith, M. A., Parkinson, D. R., Cheson, B. D., and Friedman, M. A. Retinoids in cancer therapy. J. Clin. Oncol., 10: 839-864, 1992.
6. Meyskens, F. L., Jr., Surwit, E., Moon, T. E., Childers, J. M., Davis, J. R., Dorr, R. T., Johnson, C. S., and Alberts, D. S. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J. Natl. Cancer Inst. (Bethesda), 86: 539-543, 1994.
7. Hong, W. K., and Itri, L. M. Retinoids and human cancer. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman, (eds.), The Retinoids: Biology, Chemistry, and Medicine, pp. 597-658. New York: Raven Press, 1994.
8. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
9. Chiesa, F., Tradati, N., Marazza, M., Rossi, N., Boracchi, P., Mariani, L., Clerici, M., Formelli, F., Barzan, L., and Carrassi, A. Prevention of local relapses and new localizations of oral leukoplakia with the synthetic retinoid fenretinide (4-HPR): preliminary results. Eur. J. Cancer, 28: 97-102, 1992.
10. Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Firket, P., Rosmentz, N., Clerici, M., Soresi, E., Valente, M., Belloni, P. A., and Ravasi, G. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J. Clin. Oncol., 11: 1216-1222, 1993.
11. Lippman, S. M., Bataskis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H., and Hong, W. K. Comparison of low-dose isotretinoin with beta-carotene to prevent oral carcinogenesis. N. Engl. J. Med., 328: 15-20, 1993.
12. Benner, S. E., Pajak, T. F., Lippman, S. M., and Hong, W. K. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J. Natl. Cancer Inst. (Bethesda), 86: 140-141, 1994.
13. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., and Hong, W. K. Head and neck cancer. N. Engl. J. Med., 328: 184-194, 1993.
14. Costa, A., Sacchini, V., Bonanni, B., and D'Aiuto, G. Chemoprevention of breast cancer. Eur. J. Cancer Prev., 3: 361-364, 1994.
15. Costa, A., Formelli, F., Chiesa, F., Decensi, A., DePalo, G., and Veronesi, U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res., 54 (Suppl.): 2032s-2037s, 1994.
16. Benbrook, D., Lernhardt, E., and Pfahl, M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature (Lond.), 333: 669-672, 1988.
17. Brand, N., Petkovich, M., Krust, A., Chambon, P., de The, H., Marchio, A., Tiollais, P., and Dejean, A. Identification of a second human retinoic acid receptor. Nature (Lond.), 332: 850-853, 1988.
18. Giguere, V., Ong, E. S., Segui, P., and Evans, R. M. Identification of a receptor for the morphogen retinoic acid. Nature (Lond.), 330: 624-629, 1987.
19. Krust, A., Kastner, P., Petkovich, M., Zelent, A., and Chambon, P. A third human retinoic acid receptor, hRARγ. Proc. Natl. Acad. Sci. USA, 86: 5310-5314, 1989.
20. Petkovich, M., Brand, N. J., Krust, A., and Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (Lond.), 330: 444-450, 1987.
21. Hoffmann, B., Lehmann, J. M., Zhang, X-K., Hermann, T., Husmann, M., Graupner, G., and Pfahl, M. A retinoic acid receptor-specific element controls the retinoic acid receptor-β promoter. Mol. Endocrinol., 4: 1727-1736, 1990.
22. de The, H., del Mar Vivanco-Ruiz, M., Tiollais, P., Stunnenberg, H., and Dejean, A. Identification of a retinoic acid receptor-β gene. Nature (Lond.), 343: 177-180, 1990.
23. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. Down-regulation of a retinoic acid receptor-β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth & Differ., 5: 133-141, 1994.
24. Seewaldt, V. L., Johnson, B. S., Parker, M. B., Collins, S. J., and Swisshelm, K. Expression of retinoic acid receptor β-mediated retinoid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth & Differ., 6: 1077-1088, 1995.
25. Gerbert, J. F., Moghal, N., Frangioni, J. V., Sugarbaker, D. J., and Neel, B. G. High frequency of retinoic acid receptor-β abnormalities in human lung cancer. Oncogene, 6: 1859-1868, 1991.
26. Houle, B., Leduc, F., and Bradley, W. E. C. Implications of the RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer, 3: 358-366, 1991.
27. Hu, L., Crowe, D. L., Rheinwald, J. G., Chambon, P., and Gudas, L. J. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell lines. Cancer Res., 51: 3972-3981, 1991.
28. Houle, B., Rochette-Egly, C., and Bradley, W. E. C. Tumor-suppressive effect of the retinoic acid receptor-β in human epidermoid lung cancer cells. Proc. Natl. Acad. Sci. USA, 90: 958-989, 1993.
29. van der Berg, B., van der Leede, B-J. M., Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. Retinoic acid resistance of estradiol-independent breast cancer cell lines coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol., 97: 149-157, 1993.
30. Roman, S. D., Clarke, C. L., Hall, R. E., Alexander, I. E., and Sutherland, R. L. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res., 52: 2236-2242, 1992.
31. Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
32. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
33. Arrends, M. J., Morris, R. G., and Wyllie, A. H. Apoptosis: the role of endonuclease. Am. J. Pathol., 136: 593-608, 1990.
34. Gorczyca, W., Gong, J., and Darzynkiewicz, Z. Detection of DNA strand breaks in individual cells by the in situ terminal deoxynucleotidyl transferase and nick translation assay. Cancer Res., 53: 1945-1951, 1993.
35. Clarke, R. A., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and -independent pathways. Nature (Lond.), 362: 849-852, 1993.
36. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell, 71: 587-597, 1992.
37. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
38. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potent mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
39. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
40. Xiong, Y., Hannon, G. L., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
41. Jiang, H., Lin, J., Su, Z-Z., Collart, F. R., Huberman, E., and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.
42. Wolf, D., and Rotter, V. Major deletions in the gene encoding the p53 tumor antigen cause lack of expression in HL-60 cells. Proc. Natl. Acad. Sci. USA, 82: 790-794, 1985.
43. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
44. Toyoshima, H., and Hunter, T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity related to p21. Cell, 78: 67-74, 1994,
45. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition of cell cycle arrest. Genes Dev., 8: 9-22, 1994.
46. Buchkovich, K., Duffy, L. A., and Harlow, E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58: 1097-1105, 1989.
47. Hinds, P. W., Mittnacht, S., Dulie, V., Arnold, A., Reed, S. I., and Weinberg, R. A., Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70: 993-1006, 1992.
48. Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A and Weinberg, R. A. Physical interactions of the retinoblastoma protein with human D cyclins. Cell, 73: 499-511, 1993.
49. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J-Y., and Livingston, D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73: 487-497, 1993.
50. Kato, J-Y., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7: 331-342, 1993.
51. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J-Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14: 2066-2076, 1994.
52. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
53. Zhu, X., Ohtsubo, M., Bohmer, R. M., Roberts, J. M., and Assoian, R. K. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2 and the phosphorylation of the retinoblastoma protein. J. Cell Biol., 133: 391-403, 1996.
54. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell, 79: 573-582, 1994.
55. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Bataskis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Tothe, B. B., Kramer, A., Dimery, I. W., Skipper, P., and Strong, S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
56. Liu, Y., Lee, M. O., Wang, H. G., Li, Y., Hashimoto, Y., Klaus, M., Reed, J. C., and Zhang, X. K. Retinoic acid receptor-β mediates the growth-inhibitory effects of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol., 16: 1138-1149, 1996.
57. Soprano, D. R., Gyda, M., Jiang, H., Harnish, D. C., Ugen, K., Satre, M., and Kochhar, D. M. A sustained elevation in retinoic acid receptor-beta2 mRNA and protein occurs during retinoic acid induced fetal dysmorphogenesis. Mech. Dev., 45: 243-253, 1994.
58. Soule, H. D., Maloney, T. M., Wolman, S. R., Petersen, W. D., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6075-6086, 1990.
59. Sherr, C. J. Cancer cell cycles. Science (Washington DC) 274: 1672-1677, 1996.
60. Wang, T. C., Cardiff, R. D., Zukenberg, L., Less, E., Arnold, A., and Schmidt, E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 369: 669-671, 1994.
61. Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazell, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., and Weinberg, R. A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82: 621-630, 1995.
62. Wilcken, N. R. C., Scarcevic, B., Musgrove, E. A., and Sutherland, R. L. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Cell Growth & Differ., 7: 65-74, 1996.
63. Stampfer, M. Isolation and growth of human mammary epithelial cells. J. Tissue Culture Method, 9: 107, 1985.
64. Russell, W. C., Newman, C., and Williamson, D. H. A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature (Lond.), 253: 461-462, 1975.
65. Rio, M. C., Bellocq, J. P., Gairard, B., Rasmussen, U. B., Krust, A., Koehl, C., Calderoli, H., Schiff, V., Renaud, R., and Chambon, P. Specific expression of the pS2 gene in subclasses of breast cancer in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc. Natl. Acad. Sci. USA, 84: 9243-9247, 1987.
66. Geballe, A., Spate, R., and Mocarski, E. A cis-acting element within the 5′ leader of a cytomegalovirus beta transcript determines kinetic class. Cell, 46: 865-876, 1986.
67. Tsai, S., Bartelmez, S., Heyman, R., Damm, K., Evans, R., and Collins, S. J. A mutated retinoic acid receptor-α exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev., 6: 2258-2269, 1992.
68. Karnovsky, M. J. A formaldehyde fixative of high osmolarity for use in electron microscopy. J. Cell. Biol., 27: 137, 1965.
69. Park, J., Robertson, K., Hickstein, D., Tsai, S., Hockenbery, D., and Collins, S. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid induced HL-60 granulocytes. Blood, 84: 440-445, 1994.